Salvianolic acid B inhibits the TGF-β pathway through downregulation of SMAD2/3/4 expression, which in turn inhibits the activation of tumour-associated fibroblasts and reshapes the tumour microenvironment [119]. This evidence concerns the gene SMAD2 and neoplasm.